{"id":23186,"date":"2026-10-26T10:27:12","date_gmt":"2026-10-26T08:27:12","guid":{"rendered":"https:\/\/farmacija-mic.lv\/?p=23186"},"modified":"2026-10-26T10:27:13","modified_gmt":"2026-10-26T08:27:13","slug":"olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/","title":{"rendered":"\u201cOlpha\u201d sadarb\u012bb\u0101 ar starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d Baltij\u0101 ievies\u012bs jaunu medikamentu diab\u0113ta \u0101rst\u0113\u0161anai"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Latvijas z\u0101\u013cu ra\u017eot\u0101js \u201cOlpha\u201d nosl\u0113dzis sadarb\u012bbas l\u012bgumu ar \u0160veic\u0113 b\u0101z\u0113to starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d par jauna medikamenta ievie\u0161anu Baltijas valstu tirg\u016b 2. tipa cukura diab\u0113ta \u0101rst\u0113\u0161anai un \u0137erme\u0146a svara kontrolei. Sadarb\u012bba papla\u0161in\u0101s \u201cOlpha\u201d produktu kl\u0101stu cukura diab\u0113ta \u0101rst\u0113\u0161an\u0101.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L\u012bgums parakst\u012bts farm\u0101cijas nozares izst\u0101d\u0113 \u201cCPHI Milan\u201d \u0161\u0101 gada oktobra s\u0101kum\u0101, un paredz\u0113ts, ka jaunais medikaments pacientiem b\u016bs pieejams jau tuv\u0101kaj\u0101 laik\u0101. Sadarb\u012bba apvieno \u201cAdalvo\u201d pieredzi farm\u0101cijas produktu izstr\u0101d\u0113 un pieg\u0101d\u0113 ar \u201cOlpha\u201d tirdzniec\u012bbas infrastrukt\u016bru, tirgus p\u0101rzin\u0101\u0161anu un kl\u0101tb\u016btni vis\u0101s trij\u0101s Baltijas valst\u012bs.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Jaunas \u0101rst\u0113\u0161anas iesp\u0113jas Latvij\u0101 ir \u012bpa\u0161i noz\u012bm\u012bgas, jo valst\u012b re\u0123istr\u0113ti vair\u0101k nek\u0101 100 t\u016bksto\u0161i cukura diab\u0113ta pacientu. Saska\u0146\u0101 ar Slim\u012bbu profilakses un kontroles centra datiem 2025. gada beig\u0101s Latvij\u0101 bija re\u0123istr\u0113ti 105 608 cukura diab\u0113ta pacienti, kas ir par 2,1 % vair\u0101k nek\u0101 gadu iepriek\u0161. Savuk\u0101rt gada laik\u0101 cukura diab\u0113ts pirmoreiz re\u0123istr\u0113ts aptuveni 7000 cilv\u0113ku.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Savlaic\u012bga diagnostika, piem\u0113rota \u0101rst\u0113\u0161ana un regul\u0101ra vesel\u012bbas uzraudz\u012bba var pal\u012bdz\u0113t nov\u0113rst vai aizkav\u0113t slim\u012bbas komplik\u0101ciju att\u012bst\u012bbu. T\u0101d\u0113\u013c pla\u0161\u0101kas \u0101rst\u0113\u0161anas iesp\u0113jas l\u012bdztekus vesel\u012bgam uzturam un fiziskaj\u0101m aktivit\u0101t\u0113m ir b\u016btiskas pacientu apr\u016bp\u0113.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201c\u0160is l\u012bgums ir noz\u012bm\u012bgs strat\u0113\u0123isks solis uz\u0146\u0113muma att\u012bst\u012bb\u0101, jo m\u0113s akt\u012bvi papla\u0161in\u0101m gan savu kl\u0101tb\u016btni Eirop\u0101, gan produktu portfeli. Sadarb\u012bba ar \u201cAdalvo\u201d stiprina m\u016bsu pied\u0101v\u0101jumu strat\u0113\u0123iski svar\u012bgaj\u0101 diab\u0113ta un aptauko\u0161an\u0101s \u0101rst\u0113\u0161anas jom\u0101 un veido pamatu ilgtermi\u0146a izaugsmei Baltijas valst\u012bs. Apvienojot m\u016bsu re\u0123ion\u0101lo pieredzi un tirdzniec\u012bbas infrastrukt\u016bru ar \u201cAdalvo\u201d kompetenci produktu izstr\u0101d\u0113, v\u0113lamies uzlabot \u0101rst\u0113\u0161anas iesp\u0113ju pieejam\u012bbu un sniegt ilgtermi\u0146a ieguvumus pacientiem un vesel\u012bbas apr\u016bpes speci\u0101listiem Latvij\u0101, Lietuv\u0101 un Igaunij\u0101,\u201d nor\u0101da AS \u201cOlpha\u201d valdes priek\u0161s\u0113d\u0113t\u0101js Dr. chem. Juris Hme\u013c\u0146ickis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sadarb\u012bba atbilst abu uz\u0146\u0113mumu izaugsmes strat\u0113\u0123ij\u0101m. Latvijas z\u0101\u013cu ra\u017eot\u0101jam \u201cOlpha\u201d t\u0101 ir iesp\u0113ja papla\u0161in\u0101t produktu portfeli un stiprin\u0101t poz\u012bcijas Baltij\u0101, vienlaikus \u012bstenojot pla\u0161\u0101kus att\u012bst\u012bbas pl\u0101nus Eirop\u0101. Savuk\u0101rt \u201cAdalvo\u201d \u0161\u012b sadarb\u012bba stiprina poz\u012bcijas GLP-1 receptoru agonistu segment\u0101 un pal\u012bdz \u012bstenot uz\u0146\u0113muma specializ\u0113t\u0101s GLP-1 biznesa strukt\u016brvien\u012bbas strat\u0113\u0123iskos m\u0113r\u0137us. GLP-1 receptoru agonisti ir recep\u0161u medikamenti, kas atdarina dabisk\u0101 hormona GLP-1 darb\u012bbu un pal\u012bdz regul\u0113t glikozes l\u012bmeni asin\u012bs.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cUz\u0146\u0113mums \u201cAdalvo\u201d ir ap\u0146\u0113mies veidot sp\u0113c\u012bgas partner\u012bbas, lai noz\u012bm\u012bgos tirgos \u0101tr\u0101k nodro\u0161in\u0101tu piek\u013cuvi inovat\u012bv\u0101m \u0101rst\u0113\u0161anas iesp\u0113j\u0101m. \u201cOlpha\u201d stabil\u0101s poz\u012bcijas Baltij\u0101 padara uz\u0146\u0113mumu par ide\u0101lu partneri, un m\u0113s ar gandar\u012bjumu s\u0101kam kop\u012bgu darbu, lai piln\u012bb\u0101 izmantotu \u0161\u012bs sadarb\u012bbas potenci\u0101lu,\u201d nor\u0101da \u201cAdalvo\u201d izpilddirektors Anils Okajs (Anil Okay).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u0160\u012b nav pirm\u0101 abu uz\u0146\u0113mumu sadarb\u012bba. Jau 2025. gada mart\u0101 Baltijas valstu tirg\u016b non\u0101ca \u201cOlpha\u201d un \u201cAdalvo\u201d kop\u012bgi izstr\u0101d\u0101ts \u0123en\u0113riskais antibakteri\u0101lais medikaments ur\u012bnce\u013cu infekciju \u0101rst\u0113\u0161anai.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Par jaun\u0101 diab\u0113ta \u0101rst\u0113\u0161anas medikamenta tirdzniec\u012bbas nosaukumu un pieejam\u012bbu Baltijas valst\u012bs uz\u0146\u0113mumi inform\u0113s atsevi\u0161\u0137i.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Avots: LETA<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Latvijas z\u0101\u013cu ra\u017eot\u0101js \u201cOlpha\u201d nosl\u0113dzis sadarb\u012bbas l\u012bgumu ar \u0160veic\u0113 b\u0101z\u0113to starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d par jauna medikamenta ievie\u0161anu Baltijas valstu tirg\u016b 2. tipa cukura diab\u0113ta \u0101rst\u0113\u0161anai un \u0137erme\u0146a svara kontrolei. [&hellip;]<\/p>\n","protected":false},"author":37,"featured_media":13943,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[76],"tags":[1511,279,833],"mic_flag":[],"class_list":["post-23186","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunakie-raksti","tag-adalvo","tag-diabets","tag-olpha"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Latvijas z\u0101\u013cu ra\u017eot\u0101js \u201cOlpha\u201d nosl\u0113dzis sadarb\u012bbas l\u012bgumu ar \u0160veic\u0113 b\u0101z\u0113to starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d par jauna medikamenta ievie\u0161anu Baltijas valstu tirg\u016b 2. tipa cukura diab\u0113ta \u0101rst\u0113\u0161anai un \u0137erme\u0146a svara kontrolei. Sadarb\u012bba papla\u0161in\u0101s \u201cOlpha\u201d produktu kl\u0101stu cukura diab\u0113ta \u0101rst\u0113\u0161an\u0101. L\u012bgums parakst\u012bts farm\u0101cijas nozares izst\u0101d\u0113 \u201cCPHI Milan\u201d \u0161\u0101 gada oktobra s\u0101kum\u0101, un paredz\u0113ts, ka jaunais medikaments pacientiem\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"olita@mic.lv\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"\u201cOlpha\u201d sadarb\u012bb\u0101 ar starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d Baltij\u0101 ievies\u012bs jaunu medikamentu diab\u0113ta \u0101rst\u0113\u0161anai - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"Latvijas z\u0101\u013cu ra\u017eot\u0101js \u201cOlpha\u201d nosl\u0113dzis sadarb\u012bbas l\u012bgumu ar \u0160veic\u0113 b\u0101z\u0113to starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d par jauna medikamenta ievie\u0161anu Baltijas valstu tirg\u016b 2. tipa cukura diab\u0113ta \u0101rst\u0113\u0161anai un \u0137erme\u0146a svara kontrolei. Sadarb\u012bba papla\u0161in\u0101s \u201cOlpha\u201d produktu kl\u0101stu cukura diab\u0113ta \u0101rst\u0113\u0161an\u0101. L\u012bgums parakst\u012bts farm\u0101cijas nozares izst\u0101d\u0113 \u201cCPHI Milan\u201d \u0161\u0101 gada oktobra s\u0101kum\u0101, un paredz\u0113ts, ka jaunais medikaments pacientiem\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/09\/olpha-logo-apstiprinatais-02.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/09\/olpha-logo-apstiprinatais-02.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1320\" \/>\n\t\t<meta property=\"og:image:height\" content=\"660\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-10-26T08:27:12+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-26T08:27:13+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"\u201cOlpha\u201d sadarb\u012bb\u0101 ar starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d Baltij\u0101 ievies\u012bs jaunu medikamentu diab\u0113ta \u0101rst\u0113\u0161anai - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Latvijas z\u0101\u013cu ra\u017eot\u0101js \u201cOlpha\u201d nosl\u0113dzis sadarb\u012bbas l\u012bgumu ar \u0160veic\u0113 b\u0101z\u0113to starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d par jauna medikamenta ievie\u0161anu Baltijas valstu tirg\u016b 2. tipa cukura diab\u0113ta \u0101rst\u0113\u0161anai un \u0137erme\u0146a svara kontrolei. Sadarb\u012bba papla\u0161in\u0101s \u201cOlpha\u201d produktu kl\u0101stu cukura diab\u0113ta \u0101rst\u0113\u0161an\u0101. L\u012bgums parakst\u012bts farm\u0101cijas nozares izst\u0101d\u0113 \u201cCPHI Milan\u201d \u0161\u0101 gada oktobra s\u0101kum\u0101, un paredz\u0113ts, ka jaunais medikaments pacientiem\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/09\/olpha-logo-apstiprinatais-02.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/#listItem\",\"name\":\"Jaun\\u0101kie raksti\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/#listItem\",\"position\":2,\"name\":\"Jaun\\u0101kie raksti\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\\\/#listItem\",\"name\":\"\\u201cOlpha\\u201d sadarb\\u012bb\\u0101 ar starptautisko farm\\u0101cijas uz\\u0146\\u0113mumu \\u201cAdalvo\\u201d Baltij\\u0101 ievies\\u012bs jaunu medikamentu diab\\u0113ta \\u0101rst\\u0113\\u0161anai\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\\\/#listItem\",\"position\":3,\"name\":\"\\u201cOlpha\\u201d sadarb\\u012bb\\u0101 ar starptautisko farm\\u0101cijas uz\\u0146\\u0113mumu \\u201cAdalvo\\u201d Baltij\\u0101 ievies\\u012bs jaunu medikamentu diab\\u0113ta \\u0101rst\\u0113\\u0161anai\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/#listItem\",\"name\":\"Jaun\\u0101kie raksti\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\\\/#newsarticle\",\"name\":\"\\u201cOlpha\\u201d sadarb\\u012bb\\u0101 ar starptautisko farm\\u0101cijas uz\\u0146\\u0113mumu \\u201cAdalvo\\u201d Baltij\\u0101 ievies\\u012bs jaunu medikamentu diab\\u0113ta \\u0101rst\\u0113\\u0161anai - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"\\u201cOlpha\\u201d sadarb\\u012bb\\u0101 ar starptautisko farm\\u0101cijas uz\\u0146\\u0113mumu \\u201cAdalvo\\u201d Baltij\\u0101 ievies\\u012bs jaunu medikamentu diab\\u0113ta \\u0101rst\\u0113\\u0161anai\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/olita\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/olpha-logo-apstiprinatais-02.png\",\"width\":1320,\"height\":660},\"datePublished\":\"2026-10-26T10:27:12+02:00\",\"dateModified\":\"2026-10-26T10:27:13+02:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\\\/#webpage\"},\"articleSection\":\"Jaun\\u0101kie raksti, Adalvo, diab\\u0113ts, Olpha\",\"dateline\":\"Published on October 26, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/olita\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/olita\\\/\",\"name\":\"olita@mic.lv\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a4e749f03194dabf8c7c2f4d535a473abc8e2ee2d36c914fde7dd2e7e1273ec?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"olita@mic.lv\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\\\/\",\"name\":\"\\u201cOlpha\\u201d sadarb\\u012bb\\u0101 ar starptautisko farm\\u0101cijas uz\\u0146\\u0113mumu \\u201cAdalvo\\u201d Baltij\\u0101 ievies\\u012bs jaunu medikamentu diab\\u0113ta \\u0101rst\\u0113\\u0161anai - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Latvijas z\\u0101\\u013cu ra\\u017eot\\u0101js \\u201cOlpha\\u201d nosl\\u0113dzis sadarb\\u012bbas l\\u012bgumu ar \\u0160veic\\u0113 b\\u0101z\\u0113to starptautisko farm\\u0101cijas uz\\u0146\\u0113mumu \\u201cAdalvo\\u201d par jauna medikamenta ievie\\u0161anu Baltijas valstu tirg\\u016b 2. tipa cukura diab\\u0113ta \\u0101rst\\u0113\\u0161anai un \\u0137erme\\u0146a svara kontrolei. Sadarb\\u012bba papla\\u0161in\\u0101s \\u201cOlpha\\u201d produktu kl\\u0101stu cukura diab\\u0113ta \\u0101rst\\u0113\\u0161an\\u0101. L\\u012bgums parakst\\u012bts farm\\u0101cijas nozares izst\\u0101d\\u0113 \\u201cCPHI Milan\\u201d \\u0161\\u0101 gada oktobra s\\u0101kum\\u0101, un paredz\\u0113ts, ka jaunais medikaments pacientiem\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/olita\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/olita\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/olpha-logo-apstiprinatais-02.png\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\\\/#mainImage\",\"width\":1320,\"height\":660},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\\\/#mainImage\"},\"datePublished\":\"2026-10-26T10:27:12+02:00\",\"dateModified\":\"2026-10-26T10:27:13+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"\u201cOlpha\u201d sadarb\u012bb\u0101 ar starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d Baltij\u0101 ievies\u012bs jaunu medikamentu diab\u0113ta \u0101rst\u0113\u0161anai - Medikamentu Inform\u0101cijas Centrs","description":"Latvijas z\u0101\u013cu ra\u017eot\u0101js \u201cOlpha\u201d nosl\u0113dzis sadarb\u012bbas l\u012bgumu ar \u0160veic\u0113 b\u0101z\u0113to starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d par jauna medikamenta ievie\u0161anu Baltijas valstu tirg\u016b 2. tipa cukura diab\u0113ta \u0101rst\u0113\u0161anai un \u0137erme\u0146a svara kontrolei. Sadarb\u012bba papla\u0161in\u0101s \u201cOlpha\u201d produktu kl\u0101stu cukura diab\u0113ta \u0101rst\u0113\u0161an\u0101. L\u012bgums parakst\u012bts farm\u0101cijas nozares izst\u0101d\u0113 \u201cCPHI Milan\u201d \u0161\u0101 gada oktobra s\u0101kum\u0101, un paredz\u0113ts, ka jaunais medikaments pacientiem","canonical_url":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/#listItem","name":"Jaun\u0101kie raksti"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/#listItem","position":2,"name":"Jaun\u0101kie raksti","item":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/#listItem","name":"\u201cOlpha\u201d sadarb\u012bb\u0101 ar starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d Baltij\u0101 ievies\u012bs jaunu medikamentu diab\u0113ta \u0101rst\u0113\u0161anai"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/#listItem","position":3,"name":"\u201cOlpha\u201d sadarb\u012bb\u0101 ar starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d Baltij\u0101 ievies\u012bs jaunu medikamentu diab\u0113ta \u0101rst\u0113\u0161anai","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/#listItem","name":"Jaun\u0101kie raksti"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/#newsarticle","name":"\u201cOlpha\u201d sadarb\u012bb\u0101 ar starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d Baltij\u0101 ievies\u012bs jaunu medikamentu diab\u0113ta \u0101rst\u0113\u0161anai - Medikamentu Inform\u0101cijas Centrs","headline":"\u201cOlpha\u201d sadarb\u012bb\u0101 ar starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d Baltij\u0101 ievies\u012bs jaunu medikamentu diab\u0113ta \u0101rst\u0113\u0161anai","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/olita\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/09\/olpha-logo-apstiprinatais-02.png","width":1320,"height":660},"datePublished":"2026-10-26T10:27:12+02:00","dateModified":"2026-10-26T10:27:13+02:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/#webpage"},"articleSection":"Jaun\u0101kie raksti, Adalvo, diab\u0113ts, Olpha","dateline":"Published on October 26, 2026."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/olita\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/olita\/","name":"olita@mic.lv","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/0a4e749f03194dabf8c7c2f4d535a473abc8e2ee2d36c914fde7dd2e7e1273ec?s=96&d=mm&r=g","width":96,"height":96,"caption":"olita@mic.lv"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/","name":"\u201cOlpha\u201d sadarb\u012bb\u0101 ar starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d Baltij\u0101 ievies\u012bs jaunu medikamentu diab\u0113ta \u0101rst\u0113\u0161anai - Medikamentu Inform\u0101cijas Centrs","description":"Latvijas z\u0101\u013cu ra\u017eot\u0101js \u201cOlpha\u201d nosl\u0113dzis sadarb\u012bbas l\u012bgumu ar \u0160veic\u0113 b\u0101z\u0113to starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d par jauna medikamenta ievie\u0161anu Baltijas valstu tirg\u016b 2. tipa cukura diab\u0113ta \u0101rst\u0113\u0161anai un \u0137erme\u0146a svara kontrolei. Sadarb\u012bba papla\u0161in\u0101s \u201cOlpha\u201d produktu kl\u0101stu cukura diab\u0113ta \u0101rst\u0113\u0161an\u0101. L\u012bgums parakst\u012bts farm\u0101cijas nozares izst\u0101d\u0113 \u201cCPHI Milan\u201d \u0161\u0101 gada oktobra s\u0101kum\u0101, un paredz\u0113ts, ka jaunais medikaments pacientiem","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/olita\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/olita\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/09\/olpha-logo-apstiprinatais-02.png","@id":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/#mainImage","width":1320,"height":660},"primaryImageOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/#mainImage"},"datePublished":"2026-10-26T10:27:12+02:00","dateModified":"2026-10-26T10:27:13+02:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"\u201cOlpha\u201d sadarb\u012bb\u0101 ar starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d Baltij\u0101 ievies\u012bs jaunu medikamentu diab\u0113ta \u0101rst\u0113\u0161anai - Medikamentu Inform\u0101cijas Centrs","og:description":"Latvijas z\u0101\u013cu ra\u017eot\u0101js \u201cOlpha\u201d nosl\u0113dzis sadarb\u012bbas l\u012bgumu ar \u0160veic\u0113 b\u0101z\u0113to starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d par jauna medikamenta ievie\u0161anu Baltijas valstu tirg\u016b 2. tipa cukura diab\u0113ta \u0101rst\u0113\u0161anai un \u0137erme\u0146a svara kontrolei. Sadarb\u012bba papla\u0161in\u0101s \u201cOlpha\u201d produktu kl\u0101stu cukura diab\u0113ta \u0101rst\u0113\u0161an\u0101. L\u012bgums parakst\u012bts farm\u0101cijas nozares izst\u0101d\u0113 \u201cCPHI Milan\u201d \u0161\u0101 gada oktobra s\u0101kum\u0101, un paredz\u0113ts, ka jaunais medikaments pacientiem","og:url":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/","og:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/09\/olpha-logo-apstiprinatais-02.png","og:image:secure_url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/09\/olpha-logo-apstiprinatais-02.png","og:image:width":1320,"og:image:height":660,"article:published_time":"2026-10-26T08:27:12+00:00","article:modified_time":"2026-10-26T08:27:13+00:00","twitter:card":"summary_large_image","twitter:title":"\u201cOlpha\u201d sadarb\u012bb\u0101 ar starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d Baltij\u0101 ievies\u012bs jaunu medikamentu diab\u0113ta \u0101rst\u0113\u0161anai - Medikamentu Inform\u0101cijas Centrs","twitter:description":"Latvijas z\u0101\u013cu ra\u017eot\u0101js \u201cOlpha\u201d nosl\u0113dzis sadarb\u012bbas l\u012bgumu ar \u0160veic\u0113 b\u0101z\u0113to starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d par jauna medikamenta ievie\u0161anu Baltijas valstu tirg\u016b 2. tipa cukura diab\u0113ta \u0101rst\u0113\u0161anai un \u0137erme\u0146a svara kontrolei. Sadarb\u012bba papla\u0161in\u0101s \u201cOlpha\u201d produktu kl\u0101stu cukura diab\u0113ta \u0101rst\u0113\u0161an\u0101. L\u012bgums parakst\u012bts farm\u0101cijas nozares izst\u0101d\u0113 \u201cCPHI Milan\u201d \u0161\u0101 gada oktobra s\u0101kum\u0101, un paredz\u0113ts, ka jaunais medikaments pacientiem","twitter:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/09\/olpha-logo-apstiprinatais-02.png"},"aioseo_meta_data":{"post_id":"23186","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"NewsArticle","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-10-26 08:27:13","updated":"2026-10-26 09:27:13"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/\" title=\"Jaun\u0101kie raksti\">Jaun\u0101kie raksti<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t\u201cOlpha\u201d sadarb\u012bb\u0101 ar starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d Baltij\u0101 ievies\u012bs jaunu medikamentu diab\u0113ta \u0101rst\u0113\u0161anai\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Jaun\u0101kie raksti","link":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/"},{"label":"\u201cOlpha\u201d sadarb\u012bb\u0101 ar starptautisko farm\u0101cijas uz\u0146\u0113mumu \u201cAdalvo\u201d Baltij\u0101 ievies\u012bs jaunu medikamentu diab\u0113ta \u0101rst\u0113\u0161anai","link":"https:\/\/farmacija-mic.lv\/en\/olpha-sadarbiba-ar-starptautisko-farmacijas-uznemumu-adalvo-baltija-ieviesis-jaunu-medikamentu-diabeta-arstesanai\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/23186","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/37"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=23186"}],"version-history":[{"count":1,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/23186\/revisions"}],"predecessor-version":[{"id":23187,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/23186\/revisions\/23187"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media\/13943"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=23186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=23186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=23186"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=23186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}